Bixiye
QP14-23 MHCP Pharmacy Benefit Exclusion for Bendamustine, Leqembi™, and Nexobrid®
Taariikhda uu dhaqangalayo Barnaamijka: Mar 08, 2023
Natiijooyinka Raadinta
Soo bandhiga 551 - 560 ee natiijooyinka 3688
Bixiye
QP15-23 Commercial Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective May 1, 2023
Taariikhda uu dhaqangalayo Barnaamijka: Mar 08, 2023
Bixiye
QP16-23 MHCP Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective April 1, 2023
Taariikhda uu dhaqangalayo Barnaamijka: Mar 08, 2023
Bixiye
QP17-23 Enhanced Benefit for Eyewear for SecureBlue (MSHO) Members
Taariikhda uu dhaqangalayo Barnaamijka: Mar 08, 2023
Bixiye
QP16R1-24 Authorization Submissions for Medical Drugs for Non-Oncologic Use
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 10, 2024
Bixiye
QP34-24 Mileage Reimbursement for Transportation Providers
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 10, 2024
Bixiye
QP32-24 Commercial Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective June 1, 2024
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 10, 2024
Bixiye
QP35-24 Inconsistent Claim Denials for Self-Administered Drugs, Medicare Advantage and Platinum Blue
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 24, 2024
Bixiye
TPO Consent for Disclosure of Part 2 Records
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2024
Diiwaangelinta & Qalmida
2025 Individual & Family Dental and Vision Plan Application